blindness glp 1 Lawsuits claiming Ozempic, other GLP-1s led to become second mass litigation over the drugs Glp1 blindness risk update :

But theyre powerful medications, and tinkering with your dose can backfire (and we dont even know if itll work how you want it to)

"While GLP-1 medications affect gastrointestinal tract motility, their quantified impact may not be as significant as previously assumed, said corresponding author, Dr Walter Chan, director of the Center of Gastrointestinal Motility and a physician in the Brigham's Division of Gastroenterology, Hepatology and Endoscopy

For patients who may benefit from GLP-1based therapies but face cost or availability barriers, it may be valuable to explore whether alternative regulatory mechanisms could help balance safety oversight with broader access

This review synthesizes the pharmacology, indications, administration strategies, adverse effects, contraindications, toxicity, and team-based care considerations for buprenorphine, providing a nuanced perspective suitable for advanced clinical practice and education

Pipeline of obesity pharmacotherapies GLP-1 receptor agonists GLP-1 RA increase satiety, reduce food intake and delay gastric emptying whilst they also stimulate insulin release and inhibit glucagon secretion in a glucose-dependent manner (Fig